Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

Further Reading

Evotec enters multiple target drug discovery collaboration with Shionogi

Evotec enters multiple target drug discovery collaboration with Shionogi

5 Oct 2010
Gentel Biosciences, RayBiotech to develop antibody array products with APiX chromogenic detection platform

Gentel Biosciences, RayBiotech to develop antibody array products with APiX chromogenic detection platform

5 Oct 2010
CrystalGenomics to present Phase I MAD study data at Arrowhead Summit

CrystalGenomics to present Phase I MAD study data at Arrowhead Summit

5 Oct 2010
BioRelix, Merck enter research collaboration to identify new antibacterial drug candidates

BioRelix, Merck enter research collaboration to identify new antibacterial drug candidates

4 Oct 2010
IRSF awards $1.5M in research grants for Rett syndrome treatment

IRSF awards $1.5M in research grants for Rett syndrome treatment

4 Oct 2010
Bionovo enters definitive agreement to raise $3.0 million in registered direct offering

Bionovo enters definitive agreement to raise $3.0 million in registered direct offering

4 Oct 2010
New caproKits enable investigation of small molecule–protein interactions

New caproKits enable investigation of small molecule–protein interactions

30 Sep 2010
Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

29 Sep 2010
Sanford-Burnham receives five-year core grant renewal from NCI

Sanford-Burnham receives five-year core grant renewal from NCI

29 Sep 2010
KAI Pharmaceuticals enrolls patients in Phase 1b study of KAI-4169 for treatment of SHPT

KAI Pharmaceuticals enrolls patients in Phase 1b study of KAI-4169 for treatment of SHPT

27 Sep 2010
Cellectis bioresearch launches e-store to improve access to meganuclease technology

Cellectis bioresearch launches e-store to improve access to meganuclease technology

27 Sep 2010
Cylene commences CX-4945 Phase I trial in multiple myeloma

Cylene commences CX-4945 Phase I trial in multiple myeloma

24 Sep 2010
Belfer Institute, sanofi-aventis collaborate to discover anticancer drugs

Belfer Institute, sanofi-aventis collaborate to discover anticancer drugs

24 Sep 2010
BioSeek signs two-year agreement with Cellzome

BioSeek signs two-year agreement with Cellzome

24 Sep 2010
CytomX Therapeutics completes $30 million Series B financing

CytomX Therapeutics completes $30 million Series B financing

23 Sep 2010
NCI selects Caliper's Quantum FX microCT system to study tumor models in lung cancer

NCI selects Caliper's Quantum FX microCT system to study tumor models in lung cancer

23 Sep 2010
Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

23 Sep 2010
Phenex Pharmaceuticals announces closure of Series C financing round

Phenex Pharmaceuticals announces closure of Series C financing round

21 Sep 2010
Researchers discover new drug to control acute and chronic pain

Researchers discover new drug to control acute and chronic pain

21 Sep 2010
Cellectis bioresearch, Helix Biocon collaborate to promote cGPS service in India

Cellectis bioresearch, Helix Biocon collaborate to promote cGPS service in India

20 Sep 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback